Diagnostic_test_results, 67.83258588998959
Treatment, 55.42177108908269
Causes_risk_factors, 46.61293651389
Signs_symptoms, 27.14790356326413
Antihypertensive Agents, 5.307996651041669
Cardiac Arrhythmia, 3.757814062095133
Myocardial disease, 3.2590299036458337
Vasodilator Agents, 3.0452954557291667
Diuretics, 2.568850656982423
Conduction disorder of the heart, 2.358351438201124
Neuromuscular Diseases, 1.9997270136295575
myopathy, 1.8526025527994796
vasoactive agent, 1.7934677561848962
Anti-Arrhythmia Agents, 1.7580583333333335
Connective tissue disease, 1.7520450260416673
Antineoplastic Agents, 1.4193421875000003
Anticoagulants, 1.2009984375
Pain, 1.1885273437500001
Heart valve disease, 1.1874781250000002
hypertension, 1.1325468750000003
Electrocardiography, 1.0963687500000003
Echocardiography, 1.087125
Dyspnea, 1.0839375000000002
Blood Tests, 1.075225
Myocardial Ischemia, 0.9471353125000002
Swelling, 0.9209659375000002
Abnormal electrocardiogram, 0.9150000000000001
Abnormal cardiac conduction, 0.9032793646647137
Infectious Diseases, 0.8237110458984378
Cardiac Catheterization Procedures, 0.8204375000000002
Edema, 0.7915375
angiogram, 0.7618937500000001
Electrolytes abnormal, 0.7237500000000001
Angiotensin-Converting Enzyme Inhibitors, 0.7024999999999999
X-Ray Computed Tomography, 0.6950625000000001
Anti-Inflammatory Agents, 0.6821531250000001
Adrenergic beta-Antagonists, 0.6663395833333334
Kidney Function Tests, 0.66
heart valve replacement, 0.66
Ventricular Function, 0.6479937500000001
Supraventricular arrhythmia, 0.638325
Thyroid Diseases, 0.6272484375000001
Magnetic Resonance Imaging, 0.6217500000000001
Repair of heart valve, 0.6217500000000001
Fluid overload, 0.6139034375000001
Amyloidosis, 0.6111250000000001
Renal Insufficiency, 0.6054671875000001
Phosphodiesterase Inhibitors, 0.5898750000000001
Primary cardiomyopathy, 0.5585312500000001
Hypoxemia, 0.5525325078125001
Vital signs, 0.5504562500000001
Added heart sounds, 0.5500312500000002
Shock, 0.5406560488281251
Operative Surgical Procedures, 0.5364046875000001
Digoxin, 0.5325000000000001
Implantation of ventricular assist device, 0.5325000000000001
Disorder of pericardium, 0.5229375
Myocarditis, 0.5229375
Revascularization - action, 0.5186875
Congenital heart disease, 0.5133750000000001
Pulmonary Edema, 0.5133750000000001
Cardiac implant device, 0.5133750000000001
Lipid Metabolism Disorders, 0.5093109375
Cardiomegaly, 0.50735859375
Viral infection, 0.5005781835937502
Chronic myocardial ischemia, 0.48511250000000006
Biopsy of heart, 0.483625
Ventricular Septal Defects, 0.46875000000000006
Liver Function Tests, 0.46875000000000006
Cardiovascular monitoring, 0.46875000000000006
Angina Pectoris, 0.46875000000000006
Renal vascular disorder, 0.4591875000000001
Heart Block, 0.45804182617187505
Sleep disturbances, 0.44962500000000005
Atrial arrhythmia, 0.44431250000000005
Calcium Channel Blockers, 0.44107187500000006
collagen vascular disease, 0.44024179687500004
Antilipemic agent, 0.4400625000000001
Potassium Sparing Diuretics, 0.43903478027343756
Ventricular arrhythmia, 0.42773750000000005
Tachycardia, 0.42048018229166667
Cardiac ventriculography, 0.41987500000000005
rheumatism, 0.41169375
vasopressor, 0.41084375
Kidney Failure, 0.41084375
Arteriosclerosis, 0.40934296875000015
Collagen Diseases, 0.40792187500000004
Stroke Volume, 0.405
Oxygen saturation measurement, 0.405
Brain natriuretic peptide measurement, 0.405
Antiplatelet Agents, 0.405
Apnea_ Sleep, 0.405
New York Heart Classification finding, 0.405
Magnetic Resonance Imaging (MRI) of Heart, 0.405
hydralazine, 0.39703125000000006
Iron Overload, 0.3954375000000001
Substance Abuse, 0.3954375000000001
Thiazide Diuretics, 0.3905234375
Opiates, 0.3858750000000001
Depressive disorder, 0.3858750000000001
Hypertrophy, 0.3858750000000001
person_attribute, 0.3858750000000001
Loop Diuretics, 0.38375000000000004
Myocardial Revascularization, 0.38375000000000004
Abnormal renal function, 0.38375000000000004
Chest Pain, 0.377109375
Digitalis, 0.37631250000000005
Angiotensin II receptor antagonist, 0.37312500000000004
sexually transmitted infectious disease, 0.37029609375000005
Isosorbide Dinitrate, 0.362234375
Bundle-Branch Block, 0.3470937500000001
Muscular Dystrophy, 0.3470937500000001
Blood glucose measurement, 0.34125000000000005
mTOR Inhibitor, 0.34125000000000005
Diabetes Mellitus, 0.34125000000000005
Elevated blood pressure, 0.34125000000000005
Hydroxymethylglutaryl-CoA Reductase Inhibitors, 0.34125000000000005
Angiotensin Receptor Antagonists, 0.340453125
Daunorubicin, 0.3316875
Hypotension, 0.3316875
Trypanosomiasis, 0.3316875
Nitroglycerin, 0.3316875
Breath Holding, 0.3316875
Left Ventricular Function, 0.32212500000000005
Sleep Disorders, 0.32212500000000005
Inotropic agent, 0.32000000000000006
Cardiac Arrest, 0.32000000000000006
Cardiomyopathy_ Dilated, 0.32000000000000006
Edema of lower extremity, 0.30937500000000007
Edema of extremity, 0.30725
Thyroid dysfunction, 0.30459375000000005
Respiratory Infections, 0.30459375000000005
Steroids, 0.30459375000000005
Organ Transplantation, 0.30459375000000005
HIV Infections, 0.30459375000000005
Monoclonal Antibodies, 0.29981250000000004
Left ventricular failure, 0.29545625000000003
Isosorbide, 0.2951330729166667
Shock_ Cardiogenic, 0.2937516015625
Anthracyclines, 0.29096718750000006
Oral hypoglycemic, 0.2775
Aquaretic, 0.2775
Defibrillation, 0.2775
Morphine, 0.2775
Ablation of atrioventricular node, 0.2775
Acute myocarditis, 0.2775
Confusion, 0.2775
Left ventricular pressure, 0.2775
heart rate, 0.2775
Apex beat displaced, 0.2775
Doxorubicin, 0.2775
trastuzumab, 0.2775
Low density lipoprotein cholesterol measurement, 0.2775
Cyanosis, 0.2775
Proteinuria, 0.2775
Syncope, 0.2775
Pulmonary Artery Wedge Pressure, 0.2775
Pleural effusion disorder, 0.2775
Anemia, 0.2775
echocardiography: chamber volume of left ventricle, 0.2775
Pulmonary function tests, 0.2775
Pulmonary artery pressure, 0.2775
Glucohemoglobin measurement, 0.2775
Perfusion Imaging, 0.2775
Urinalysis, 0.2775
Body Weight, 0.2775
Troponin measurement, 0.2775
Uric acid measurement (procedure), 0.2775
Monitoring of cardiac output/cardiac index, 0.2775
Acidosis_ Respiratory, 0.2775
Self-Management, 0.2775
Non-Invasive Ventilation, 0.2775
Family Planning, 0.2775
Positive End-Expiratory Pressure, 0.2775
Arginine vasopressin antagonist, 0.2775
Radionuclide Ventriculography, 0.2775
Intubation, 0.2775
Atrioseptoplasty, 0.2775
Anticoagulant prophylaxis, 0.2775
Cardiac support procedure, 0.2775
Angioplasty, 0.2775
Resection of left ventricle of heart, 0.2775
Pericardiocentesis, 0.2775
metoprolol succinate, 0.2775
Antidepressive Agents, 0.2775
Cardiac Resynchronization Therapy, 0.2775
nutritional supplements, 0.2775
Cardiovascular stress testing, 0.2775
Cyclooxygenase 2 Inhibitors, 0.2775
Echocardiography_ Doppler, 0.2775
Abdominal Pain, 0.2775
Insulin Resistance, 0.2775
Anomalous origin of coronary artery, 0.2775
Chronic Obstructive Airway Disease, 0.2775
acute myocardial infarction, 0.2775
Antidepressants_ Tricyclic, 0.2775
Acromegaly, 0.2775
Blacks, 0.2775
Sarcoidosis, 0.2775
Carbamazepine, 0.2775
Thiamine Deficiency, 0.2775
Pulmonary Embolism, 0.2775
Tachycardia_ Ventricular, 0.2775
Thiazolidinediones, 0.2775
Family history, 0.2775
Abdomen distended, 0.2775
Holter Electrocardiography, 0.2775
Positron-Emission Tomography, 0.2775
Heart_ Artificial, 0.2775
Restrictive cardiomyopathy, 0.2775
Bisoprolol, 0.2775
Coughing, 0.2775
sex, 0.2775
Transposition of Great Vessels, 0.2775
Mental Depression, 0.2775
Mitral valvuloplasty, 0.2775
Cachexia, 0.2775
Rales, 0.2775
Fatigue, 0.2775
CT angiography, 0.2775
Obesity, 0.2775
Acute pulmonary edema, 0.2775
Valvuloplasty of aortic valve, 0.2775
Coronary heart disease, 0.27510937500000004
Blood Cell Count, 0.2743125
mitral valvular disease, 0.2743125
Myocardial Infarction, 0.27112500000000006
Hemoglobin measurement, 0.26793750000000005
Exercise stress test, 0.26793750000000005
Electrocardiography_ Ambulatory, 0.26793750000000005
Anti-Inflammatory Agents_ Non-Steroidal, 0.26793750000000005
spironolactone, 0.25917187500000005
Rheumatic Fever, 0.2590833333333334
Atrioventricular Block, 0.25625000000000003
Dyspnea_ Paroxysmal, 0.25625000000000003
Mineralocorticoid Receptor Antagonists, 0.2504958984375001
Aldosterone Antagonists, 0.2504958984375001
Dihydropyridine Calcium Channel Blocker, 0.249875
Peripheral edema, 0.24562500000000004
Tumor Necrosis Factor (TNF) Inhibitors, 0.24562500000000004
Anti-tumor necrosis factor alpha drug, 0.24562500000000004
tachyarrhythmia, 0.24485468750000006
Antithrombins, 0.24084375000000002
Polyunsaturated Fatty Acids, 0.24084375000000002
FISH OIL, 0.24084375000000002
chronic kidney diseases, 0.24084375000000002
Left Ventricular Hypertrophy, 0.24084375000000002
Dyslipidemias, 0.24084375000000002
Atherosclerosis, 0.23925000000000002
Rheumatic Heart Disease, 0.23500000000000004
Pulse Rate, 0.22862500000000002
Cardiac rhythm type, 0.22862500000000002
Metoprolol, 0.22862500000000002
Radionuclide Angiography, 0.22862500000000002
isosorbide-hydralazine combination, 0.22437500000000005
Supraventricular tachycardia, 0.22437500000000005
Intraventricular conduction defect, 0.22375742187500003
Amiodarone, 0.21375000000000002
pneumonia, 0.21375000000000002
Carbonic Anhydrase Inhibitors, 0.21375000000000002
Pericardial effusion, 0.21375000000000002
Acquired Immunodeficiency Syndrome, 0.21375000000000002
Adrenal Cortex Hormones, 0.21375000000000002
hyperthyroidism, 0.21375000000000002
eplerenone, 0.21375000000000002
Chagas Disease, 0.21375000000000002
Omega-3 Fatty Acids, 0.21375000000000002
Mitral Regurgitation, 0.21375000000000002
Ventricular Function_ Right, 0.21375000000000002
Gallop rhythm, 0.21375000000000002
Transdermal nitroglycerin, 0.21375000000000002
Kidney Failure_ Chronic, 0.21375000000000002
Pulmonary Hypertension, 0.21375000000000002
brugada syndrome, 0.21375000000000002
Hyperlipidemia, 0.21375000000000002
heparin, 0.21375000000000002
Hemochromatosis, 0.21375000000000002
Epinephrine, 0.21375000000000002
Q wave - finding, 0.21375000000000002
Glucose measurement_ fasting, 0.21375000000000002
Heart valve stenosis, 0.21375000000000002
Blood pressure determination, 0.21375000000000002
Cardiac ejection fraction, 0.21375000000000002
Bilirubin Measurement, 0.21375000000000002
Ventricular Dysfunction_ Left, 0.21375000000000002
Selective factor Xa inhibitor, 0.21375000000000002
Renal Replacement Therapy, 0.21375000000000002
Cardiac pacing, 0.21375000000000002
Sirolimus, 0.21375000000000002
Natriuretic Peptides, 0.21375000000000002
Vitamins, 0.21375000000000002
Ultrafiltration, 0.21375000000000002
terminal patient care, 0.21375000000000002
Heart Transplantation, 0.21375000000000002
Palliative Care, 0.21375000000000002
Cardiac ablation, 0.21375000000000002
peripheral vascular disease, 0.21375000000000002
Endocarditis, 0.21375000000000002
Adrenergic beta-Agonists, 0.21375000000000002
Muscular Dystrophy_ Duchenne, 0.21375000000000002
Storage disease, 0.21375000000000002
Androgens, 0.21375000000000002
Hypertension induced by pregnancy, 0.21375000000000002
Alcohol abuse, 0.21375000000000002
Anticoagulants_ Oral, 0.21375000000000002
Renin inhibitor, 0.21375000000000002
Atrial Fibrillation, 0.21375000000000002
Renal Artery Stenosis, 0.21375000000000002
Familial cardiomyopathy, 0.21375000000000002
Systolic Murmurs, 0.21375000000000002
Heart murmur, 0.21375000000000002
Hypertrophic Cardiomyopathy, 0.21375000000000002
Cardiac CT, 0.21375000000000002
Hypertensive cardiovascular disease, 0.21375000000000002
Respiration intermittent, 0.21375000000000002
Coronary angiography, 0.21375000000000002
Swelling of limb, 0.21375000000000002
S3 - Third heart sound, 0.21375000000000002
Valvular regurgitation, 0.21056250000000004
Pulmonary vascular disorder, 0.19542187500000002
Cor pulmonale, 0.19542187500000002
Myocardial biopsy, 0.19250000000000003
Complete Blood Count, 0.19250000000000003
Systemic amyloidosis, 0.19250000000000003
Arginine, 0.19250000000000003
Endothelin receptor antagonist, 0.19250000000000003
nitroprusside, 0.19250000000000003
Phosphodiesterase 5 inhibitor, 0.19250000000000003
Bradycardia, 0.19250000000000003
Nocturnal dyspnea, 0.19250000000000003
Thiazides, 0.18864843750000004
Chlorothiazide, 0.181875
Lupus Erythematosus, 0.181875
Left Bundle-Branch Block, 0.181875
Hydralazine Hydrochloride, 0.181875
Rheumatic disease of heart valve, 0.15000000000000002
Rheumatoid Arthritis, 0.15000000000000002
Acute rheumatic heart disease, 0.15000000000000002
Sulfonylurea Compounds, 0.15000000000000002
dronedarone, 0.15000000000000002
Acetazolamide, 0.15000000000000002
Metolazone, 0.15000000000000002
1_3-dipropyl-8-(3-noradamantyl)xanthine, 0.15000000000000002
indapamide, 0.15000000000000002
chlorthalidone, 0.15000000000000002
Ularitide, 0.15000000000000002
Bendroflumethiazide, 0.15000000000000002
Furosemide, 0.15000000000000002
torsemide, 0.15000000000000002
Ethacrynic Acid, 0.15000000000000002
Bumetanide, 0.15000000000000002
Amiloride, 0.15000000000000002
hydrochlorothiazide, 0.15000000000000002
triamterene, 0.15000000000000002
Direct current cardioversion, 0.15000000000000002
Calcification of pericardium, 0.15000000000000002
Hemopericardium, 0.15000000000000002
Pedal edema, 0.15000000000000002
Ankle edema (finding), 0.15000000000000002
HIV cardiomyopathy, 0.15000000000000002
Open ablation of atrioventricular node, 0.15000000000000002
Endomyocardial biopsy (procedure), 0.15000000000000002
Acute myopericarditis, 0.15000000000000002
Dermatomyositis, 0.15000000000000002
Lupus Erythematosus_ Systemic, 0.15000000000000002
Mixed Connective Tissue Disease, 0.15000000000000002
Right bundle branch block, 0.15000000000000002
Disorientation, 0.15000000000000002
Glucocorticoids, 0.15000000000000002
Left ventricular end-diastolic pressure level, 0.15000000000000002
Thyrotoxicosis, 0.15000000000000002
hypothyroidism, 0.15000000000000002
coenzyme Q10, 0.15000000000000002
Enoximone, 0.15000000000000002
Levosimendan, 0.15000000000000002
Postmyocardial infarction syndrome, 0.15000000000000002
Myocarditis due to hypersensitivity state, 0.15000000000000002
Giant cell myocarditis, 0.15000000000000002
lipid profile test, 0.15000000000000002
Hematocrit procedure, 0.15000000000000002
Radioallergosorbent Test, 0.15000000000000002
Digitek, 0.15000000000000002
Lanoxin, 0.15000000000000002
Lanoxicaps, 0.15000000000000002
Respiratory rate, 0.15000000000000002
Coronary Artery Bypass Surgery, 0.15000000000000002
Chronic Chagas' disease, 0.15000000000000002
Random blood glucose measurement, 0.15000000000000002
Fasting blood glucose, 0.15000000000000002
Eicosapentaenoic Acid, 0.15000000000000002
MaximumHeartRate, 0.15000000000000002
Apex beat displaced - LVH, 0.15000000000000002
Coronary Arteriosclerosis, 0.15000000000000002
peripheral arterial disease, 0.15000000000000002
Fluorouracil, 0.15000000000000002
Mitoxantrone, 0.15000000000000002
Interferons, 0.15000000000000002
Cyclophosphamide, 0.15000000000000002
imatinib, 0.15000000000000002
Mitomycin, 0.15000000000000002
Cytotoxic agent, 0.15000000000000002
Ventricular Remodeling, 0.15000000000000002
Ventricular End-Systolic Volume, 0.15000000000000002
Ventricular End-Diastolic Volume, 0.15000000000000002
Protodiastolic gallop with abnormally audible third heart sound, 0.15000000000000002
Nitroglycerin Transdermal Patch, 0.15000000000000002
Azotemia, 0.15000000000000002
acute renal insufficiency, 0.15000000000000002
Kidney Failure_ Acute, 0.15000000000000002
Reactive systemic amyloidosis, 0.15000000000000002
Hemodialysis-associated amyloidosis, 0.15000000000000002
Senile cardiac amyloidosis, 0.15000000000000002
Primary amyloidosis, 0.15000000000000002
Verapamil, 0.15000000000000002
Felodipine, 0.15000000000000002
Amlodipine, 0.15000000000000002
Diltiazem, 0.15000000000000002
Nifedipine, 0.15000000000000002
Wolff-Parkinson-White Syndrome, 0.15000000000000002
Hypertriglyceridemia, 0.15000000000000002
Serum LDL cholesterol measurement, 0.15000000000000002
Heparin_ Low-Molecular-Weight, 0.15000000000000002
Ventricular Septal Rupture, 0.15000000000000002
Common ventricle, 0.15000000000000002
Tetralogy of Fallot, 0.15000000000000002
First degree AV block, 0.15000000000000002
Second degree atrioventricular block, 0.15000000000000002
Complete atrioventricular block, 0.15000000000000002
Hereditary hemochromatosis, 0.15000000000000002
Isosorbide Mononitrate, 0.15000000000000002
Norepinephrine, 0.15000000000000002
Phenylephrine, 0.15000000000000002
Argipressin, 0.15000000000000002
ECG: Q wave abnormal, 0.15000000000000002
Blue lips, 0.15000000000000002
Microalbuminuria, 0.15000000000000002
Hypotension_ Orthostatic, 0.15000000000000002
Inspra, 0.15000000000000002
Volume status, 0.15000000000000002
abnormal myocardial texture, 0.15000000000000002
Left atrial pressure, 0.15000000000000002
echocardiography: enlarged left atrium, 0.15000000000000002
pet metabolic/perfusion mismatch, 0.15000000000000002
intravascular volume, 0.15000000000000002
Hyperuricemia, 0.15000000000000002
Angiotensin II, 0.15000000000000002
Diastolic dysfunction, 0.15000000000000002
Ventricular segment, 0.15000000000000002
pet metabolic deficits, 0.15000000000000002
DIGOXIN LEVEL ELEVATED, 0.15000000000000002
maximum velocities, 0.15000000000000002
end-diastolic regurgitant jet velocity, 0.15000000000000002
technetium tc 99, 0.15000000000000002
peak gradient, 0.15000000000000002
Potassium electrolyte, 0.15000000000000002
Hemoglobin low, 0.15000000000000002
noninvasive imaging, 0.15000000000000002
Ventricular enlargement, 0.15000000000000002
Oxygen Consumption, 0.15000000000000002
e/ea, 0.15000000000000002
Measurement of urine output, 0.15000000000000002
Ventricular Heart Rate, 0.15000000000000002
cardiac electrophysiology, 0.15000000000000002
Sodium electrolyte, 0.15000000000000002
e/e' ratio, 0.15000000000000002
alpha-Atrial Natriuretic Peptide, 0.15000000000000002
Left ventricular wall thickness, 0.15000000000000002
Decreased albumin, 0.15000000000000002
Echocardiography_ Stress_ Dobutamine, 0.15000000000000002
Systolic Pressure, 0.15000000000000002
Radionuclide imaging of myocardial perfusion with ejection fraction, 0.15000000000000002
3-Iodobenzylguanidine, 0.15000000000000002
6-minute walk test, 0.15000000000000002
Pulmonary Vascular Resistance, 0.15000000000000002
docosahexaenoic acid, 0.15000000000000002
Presence of Q wave, 0.15000000000000002
ECG: atrial flutter, 0.15000000000000002
proximal left anterior descending stenosis, 0.15000000000000002
nuclear imaging, 0.15000000000000002
Hypomagnesemia, 0.15000000000000002
C-reactive protein, 0.15000000000000002
echocardiography: systolic deceleration time of mitral valve, 0.15000000000000002
Maximum oxygen uptake, 0.15000000000000002
Ejection fraction normal, 0.15000000000000002
Genetic screening method, 0.15000000000000002
Left ventricular wall motion, 0.15000000000000002
modified simpson's rule, 0.15000000000000002
Hemodynamic resistance:Resistance:Point in time:Systemic vasculature:Quantitative, 0.15000000000000002
Doppler continuous wave, 0.15000000000000002
mitral inflow during valsalva manoeuvre, 0.15000000000000002
flow redistribution, 0.15000000000000002
Left ventricular wall motion abnormality, 0.15000000000000002
repolarization changes, 0.15000000000000002
echocardiography: diastolic regurgitant velocity, 0.15000000000000002
Enzyme-Linked Immunosorbent Assay, 0.15000000000000002
Pulse rhythm, 0.15000000000000002
T wave alternans, 0.15000000000000002
mechanical dyssynchrony, 0.15000000000000002
change in diameter on inspiration, 0.15000000000000002
Selenium, 0.15000000000000002
Velocity-time integral, 0.15000000000000002
Myocardial perfusion, 0.15000000000000002
measurement of the rate during moderate exercise, 0.15000000000000002
Electrocardiogram: P-R interval, 0.15000000000000002
Dietary sodium intake, 0.15000000000000002
Vital capacity, 0.15000000000000002
mean gradient, 0.15000000000000002
mass, 0.15000000000000002
Serum sodium measurement, 0.15000000000000002
qrs width, 0.15000000000000002
x-ray of chest: mass of heart, 0.15000000000000002
Contrast neuroradiography, 0.15000000000000002
pulse-wave and tissue doppler, 0.15000000000000002
HYPONATREMIA EUVOLEMIC, 0.15000000000000002
mitral inflow pattern, 0.15000000000000002
echocardiography: internal diameter of inferior vena cava, 0.15000000000000002
the ratio of early to late diastolic filling (e/a, 0.15000000000000002
Platelet Count measurement, 0.15000000000000002
preserved ef, 0.15000000000000002
Epidermal Growth Factor Receptor, 0.15000000000000002
mitral inflow e/a ratio, 0.15000000000000002
inspiratory collapse of at least 50%, 0.15000000000000002
left main coronary artery stenosis, 0.15000000000000002
Right ventricular systolic pressure increased, 0.15000000000000002
Creatine kinase MB measurement, 0.15000000000000002
Gradient.mean, 0.15000000000000002
Serum total cholesterol measurement, 0.15000000000000002
regional myocardial thinning, 0.15000000000000002
biomarkers of myocardial injury or fibrosis, 0.15000000000000002
cardiac chamber size and function, 0.15000000000000002
edpvr, 0.15000000000000002
proximal left anterior descending coronary artery stenosis, 0.15000000000000002
Pulmonary Venous Wedge Pressure, 0.15000000000000002
QRS duration:Time:Point in time:Heart:Quantitative:EKG, 0.15000000000000002
Entire inferior vena cava, 0.15000000000000002
rv size, 0.15000000000000002
velocity of early diastolic filling (evel, 0.15000000000000002
Urine volume finding, 0.15000000000000002
Left Atrium Dimension, 0.15000000000000002
heart rate variability, 0.15000000000000002
end-diastolic pressure (edp), 0.15000000000000002
E wave.max/A wave.max:VelRto:Pt:Mitral valve:Qn:US.doppler, 0.15000000000000002
(a pulm-a mitral) duration, 0.15000000000000002
chamber sizes, 0.15000000000000002
Infarction, 0.15000000000000002
teichholz, 0.15000000000000002
Ventricular filling pressure increased, 0.15000000000000002
Pulmonary venous congestion, 0.15000000000000002
Increased pulmonary arterial wedge pressure, 0.15000000000000002
echocardiography: thickness of ventricular septum, 0.15000000000000002
tapse, 0.15000000000000002
decreased fractional shortening at midwall, 0.15000000000000002
pet baseline perfusion deficits, 0.15000000000000002
systolic tissue doppler velocities, 0.15000000000000002
respiratory gaseous exchange, 0.15000000000000002
transmural extent of scar, 0.15000000000000002
Doppler echocardiography: abnormal diastolic relaxation, 0.15000000000000002
Anterior Q wave, 0.15000000000000002
Left ventricular diastolic dysfunction, 0.15000000000000002
Left ventricular ejection fraction, 0.15000000000000002
Prolonged QRS duration, 0.15000000000000002
Ambulatory continuous electrocardiography [ECG], 0.15000000000000002
Low QRS voltages, 0.15000000000000002
Electrolytes measurement_ serum, 0.15000000000000002
Electrocardiogram poor R-wave progression, 0.15000000000000002
tissue doppler imaging, 0.15000000000000002
Iodine 123 meta-iodobenzylguanidine study, 0.15000000000000002
Ferritin, 0.15000000000000002
Coronary artery calcification, 0.15000000000000002
stress test resting diastolic BP, 0.15000000000000002
cardiac valve area, 0.15000000000000002
Myocardial perfusion stress imaging using technetium 99m metaiodobenzylguanidine tetrofosmin, 0.15000000000000002
Orthostatic blood pressure, 0.15000000000000002
valve function, 0.15000000000000002
Right atrial pressure, 0.15000000000000002
T' wave amplitude.lead V1:Elpot:Pt:Heart:Qn:EKG, 0.15000000000000002
Hyperglycemia, 0.15000000000000002
Doppler Ultrasound Imaging, 0.15000000000000002
Body Surface Area, 0.15000000000000002
Cardiac blood pool imaging, 0.15000000000000002
Tissue velocity, 0.15000000000000002
x-ray of chest: pulmonary veins Kerley's B lines (linear + pleura), 0.15000000000000002
Fluid intake, 0.15000000000000002
Hypokinesia, 0.15000000000000002
Valvular disease, 0.15000000000000002
strain rate, 0.15000000000000002
apical biplane method of discs, 0.15000000000000002
99mtc-dpd scan, 0.15000000000000002
Polysomnography, 0.15000000000000002
doppler systolic and diastolic indices, 0.15000000000000002
Ventricular volume, 0.15000000000000002
tissue doppler e' wave velocity, 0.15000000000000002
echocardiography: left atrial volume, 0.15000000000000002
Right ventricular dilatation, 0.15000000000000002
Decreased cardiac ejection fraction, 0.15000000000000002
velocity of filling with atrial contraction (avel, 0.15000000000000002
electrocardiogram: intraventricular conduction delay (IVCD), 0.15000000000000002
Plasma creatinine level, 0.15000000000000002
Activity level, 0.15000000000000002
Troponin increased, 0.15000000000000002
Myocardial imaging for infarct_ planar technique, 0.15000000000000002
Ammonia N-13, 0.15000000000000002
A wave, 0.15000000000000002
left ventricular volumes, 0.15000000000000002
overnight sleep study, 0.15000000000000002
Galectin 3, 0.15000000000000002
ventricular systolic and diastolic function, 0.15000000000000002
prominent upper lobe vasculature, 0.15000000000000002
av plane systolic excursion, 0.15000000000000002
Finding of liver enzyme levels, 0.15000000000000002
deformation imaging, 0.15000000000000002
midregional fragment of proadrenomedullin, 0.15000000000000002
Body mass index procedure, 0.15000000000000002
Intravascular US scan, 0.15000000000000002
Electrocardiogram: left ventricle hypertrophy (finding), 0.15000000000000002
pseudoinfarct pattern, 0.15000000000000002
Cardiac index, 0.15000000000000002
Hematocrit level, 0.15000000000000002
Serum magnesium measurement, 0.15000000000000002
lv diastolic stiffness, 0.15000000000000002
Left atrial hypertrophy, 0.15000000000000002
Thyroid function tests abnormal, 0.15000000000000002
Hemosiderin-laden macrophage, 0.15000000000000002
elevations in bilirubin, 0.15000000000000002
lv diastolic function, 0.15000000000000002
MCHC - low, 0.15000000000000002
orthostatic testing, 0.15000000000000002
noninvasive evaluation of lv function, 0.15000000000000002
Serum digoxin measurement, 0.15000000000000002
myocardial mass, 0.15000000000000002
Peripheral oxygen saturation, 0.15000000000000002
mitral regurgitant blood flow, 0.15000000000000002
Pulmonary artery diastolic pressure, 0.15000000000000002
Sustained ventricular tachycardia, 0.15000000000000002
sparkling pattern, 0.15000000000000002
intracardiac filling pressures, 0.15000000000000002
Potassium:SCnc:Pt:Ser/Plas:Qn, 0.15000000000000002
Total Peripheral Resistance, 0.15000000000000002
Electrocardiogram P wave biphasic, 0.15000000000000002
viable lv myocardium, 0.15000000000000002
peripheral eosinophilia, 0.15000000000000002
ST segment elevation (finding), 0.15000000000000002
Bicarbonate measurement, 0.15000000000000002
viability, 0.15000000000000002
delayed enhancement from t1-weighted images, 0.15000000000000002
ST segment depression (finding), 0.15000000000000002
LDL Cholesterol Lipoproteins, 0.15000000000000002
N-terminal pro-B-type natriuretic peptide, 0.15000000000000002
abnormalities of lv diastolic filling, 0.15000000000000002
regional cardiac wall motion dysfunction, 0.15000000000000002
Plasma pro-brain natriuretic peptide level, 0.15000000000000002
Right ventricular systolic dysfunction, 0.15000000000000002
thallium activity score, 0.15000000000000002
HEART SIZE, 0.15000000000000002
Elevated serum creatine kinase, 0.15000000000000002
Monitor fluid intake and output, 0.15000000000000002
High Density Lipoprotein Cholesterol, 0.15000000000000002
pulmonary venous inflow velocities, 0.15000000000000002
Dilation of left ventricular chamber, 0.15000000000000002
Left ventricular end-diastolic cavity size, 0.15000000000000002
Ejection fraction (finding), 0.15000000000000002
atrial size and dimensions, 0.15000000000000002
biatrial enlargement, 0.15000000000000002
Peak velocity of tricuspid regurgitation, 0.15000000000000002
Dilation of left atrial chamber, 0.15000000000000002
PULMONARY EDEMA INTERSTITIAL, 0.15000000000000002
Heart sounds abnormal, 0.15000000000000002
Contraction alkalosis, 0.15000000000000002
visual assessment of ef, 0.15000000000000002
sphericity index, 0.15000000000000002
Metabolic acidosis, 0.15000000000000002
Cardiac troponin T measurement, 0.15000000000000002
Left ventricular end-systolic cavity size, 0.15000000000000002
Low Cardiac Output, 0.15000000000000002
Pleural fluid examination, 0.15000000000000002
midregional pro-atrial natriuretic peptide_ human, 0.15000000000000002
docosapentaenoic acid, 0.15000000000000002
Endothelin measurement, 0.15000000000000002
Continuous Sphygmomanometers, 0.15000000000000002
alveolar fluid, 0.15000000000000002
Measurement of gas exchange, 0.15000000000000002
increased p wave amplitude in lead ii, 0.15000000000000002
Fractional shortening.minor axis:LenFr:Pt:Heart.ventricle.left:Qn:US, 0.15000000000000002
Idioventricular rhythm, 0.15000000000000002
Nonsustained ventricular tachycardia, 0.15000000000000002
Cystatin C increased, 0.15000000000000002
Muscle strain, 0.15000000000000002
Cardiac end-diastolic volume, 0.15000000000000002
Carnitine, 0.15000000000000002
Leukocytes, 0.15000000000000002
Nonspecific Intraventricular Conduction Delay, 0.15000000000000002
doppler assessment, 0.15000000000000002
early diastolic myocardial velocities (e'), 0.15000000000000002
Isovolumic relaxation Time, 0.15000000000000002
peak mitral inflow e wave velocity, 0.15000000000000002
e', 0.15000000000000002
Electrolytes measurement, 0.15000000000000002
Pulmonary arterial systolic pressure, 0.15000000000000002
Effective regurgitant orifice, 0.15000000000000002
INTERSTITIAL MARKING INCREASED, 0.15000000000000002
end-diastolic pressure-volume relationship, 0.15000000000000002
Sodium intake, 0.15000000000000002
Digoxin measurement, 0.15000000000000002
US scan of thoracic aorta, 0.15000000000000002
Ventricular dyssynchrony, 0.15000000000000002
Abnormal, 0.15000000000000002
Chest X-ray, 0.15000000000000002
adiponectin, 0.15000000000000002
Fasting lipid profile, 0.15000000000000002
echocardiography: fractional shortening of left ventricle, 0.15000000000000002
Prothrombin time increased, 0.15000000000000002
daily sodium intake, 0.15000000000000002
Myocardial fibrosis, 0.15000000000000002
Myocardial perfusion stress imaging using Thallium 201, 0.15000000000000002
eye-balling, 0.15000000000000002
Sinus Tachycardia, 0.15000000000000002
st2, 0.15000000000000002
Plasma Uric Acid Test, 0.15000000000000002
P wave duration (observable entity), 0.15000000000000002
Left ventricular ejection fraction decreased, 0.15000000000000002
lv end-systolic volume index, 0.15000000000000002
end-systolic diameter, 0.15000000000000002
serum hemoglobin, 0.15000000000000002
lv sphericity index, 0.15000000000000002
elevated plasma natriuretic peptide concentration, 0.15000000000000002
Aspartate Transaminase, 0.15000000000000002
Right atrial enlargement, 0.15000000000000002
e/a ratio, 0.15000000000000002
prominence of the right ventricle, 0.15000000000000002
magnetic resonance imaging of heart for morphology, 0.15000000000000002
Differential white blood cell count procedure, 0.15000000000000002
International Normalized Ratio, 0.15000000000000002
valvular gradients, 0.15000000000000002
Blood Circulation Time, 0.15000000000000002
Perfusion, 0.15000000000000002
ST-Depression_Peak, 0.15000000000000002
increased salivary endothelin levels, 0.15000000000000002
Pulsed wave ultrasonic Doppler, 0.15000000000000002
Serum potassium measurement, 0.15000000000000002
systolic lv function, 0.15000000000000002
increased peak doppler peak e, 0.15000000000000002
PERIHILAR PULMONARY INFILTRATE, 0.15000000000000002
WATER_ O-15_, 0.15000000000000002
Intracardiac pressure, 0.15000000000000002
stv5 depression, 0.15000000000000002
Measurement of cardiac output, 0.15000000000000002
early (e) and atrial (a) waveforms, 0.15000000000000002
Low ventricular voltage by EKG, 0.15000000000000002
Oxygen saturation test result, 0.15000000000000002
Pulse oximeter, 0.15000000000000002
Systolic dysfunction, 0.15000000000000002
Transaminase raised, 0.15000000000000002
Pharmacologic and exercise stress test, 0.15000000000000002
"butterfly" pattern of alveolar opacities, 0.15000000000000002
Rubidium, 0.15000000000000002
qrs non-dipolar voltage, 0.15000000000000002
Continuous wave ultrasonic Doppler, 0.15000000000000002
valvular structure and function, 0.15000000000000002
Proximal Left Anterior Descending Coronary Artery Stenosis, 0.15000000000000002
Serum creatinine level, 0.15000000000000002
Deceleration time, 0.15000000000000002
left ventricular outflow tract reconstruction, 0.15000000000000002
Right ventricular cavity size, 0.15000000000000002
Nuclear Stress Test, 0.15000000000000002
Fatty acids.omega 3:SCnc:Pt:Ser/Plas:Qn, 0.15000000000000002
soluble st2, 0.15000000000000002
left ventricular filling pressure, 0.15000000000000002
Cardiovascular stress test using treadmill, 0.15000000000000002
sodium excretion, 0.15000000000000002
engorged hilar pulmonary arteries, 0.15000000000000002
Cardiovascular stress test using bicycle ergometer, 0.15000000000000002
Glomerular filtration rate decreased, 0.15000000000000002
mitral valve inflow pattern, 0.15000000000000002
Right ventricular systolic pressure level, 0.15000000000000002
Left atrium cavity size, 0.15000000000000002
Left ventricular isovolumic relaxation, 0.15000000000000002
serum Calcium measurement, 0.15000000000000002
hrv, 0.15000000000000002
memorial symptom assessment scale, 0.15000000000000002
Hydrogen Carbonate, 0.15000000000000002
CHEST XRAY PULMONARY VASCULAR REDISTRIBUTION, 0.15000000000000002
atrial heart rate and rhythm, 0.15000000000000002
Intracardiac mass, 0.15000000000000002
creatinine concentration (serum or plasma), 0.15000000000000002
Dilated left ventricle, 0.15000000000000002
Aldosterone measurement_ serum, 0.15000000000000002
Left ventricular mass, 0.15000000000000002
QRS complex duration (observable entity), 0.15000000000000002
Urine albumin measurement, 0.15000000000000002
diffuse hypokinesis, 0.15000000000000002
Intracardiac thrombus, 0.15000000000000002
cardiac evaluation of right heart pressure, 0.15000000000000002
Left ventricular size, 0.15000000000000002
Serum cystatin C measurement, 0.15000000000000002
Gradient.systole.max:Pres:Pt:Tricuspid valve.regurgitant jet:Qn:US.doppler, 0.15000000000000002
Wedge Pressure, 0.15000000000000002
C-reactive protein measurement, 0.15000000000000002
ECG: atrial fibrillation, 0.15000000000000002
Triglycerides, 0.15000000000000002
Alveolar edema, 0.15000000000000002
lv wall motion score index, 0.15000000000000002
Left ventricular end-diastolic dimension, 0.15000000000000002
Left ventricular systolic dysfunction, 0.15000000000000002
Arterial Lines, 0.15000000000000002
Chlorides, 0.15000000000000002
Serum creatinine raised, 0.15000000000000002
Renin measurement, 0.15000000000000002
interventricular conduction delay, 0.15000000000000002
Valsalva Maneuver, 0.15000000000000002
Valvular function features, 0.15000000000000002
Cardiac biomarkers, 0.15000000000000002
electrocardiogram: axis QRST angle, 0.15000000000000002
Neutrophilia, 0.15000000000000002
Thiamine, 0.15000000000000002
lv regional function, 0.15000000000000002
echocardiography: valvular mitral stenosis, 0.15000000000000002
lv outflow tract velocity time integral, 0.15000000000000002
lv end-systolic diameter, 0.15000000000000002
Measurement of central venous pressure, 0.15000000000000002
Fluoroscopy_Vessels_Test, 0.15000000000000002
Serum albumin measurement, 0.15000000000000002
left atrial volume index, 0.15000000000000002
peribronchial cuffing, 0.15000000000000002
Left ventricular end-systolic dimension, 0.15000000000000002
Color doppler ultrasound, 0.15000000000000002
myosin light chain kinase i, 0.15000000000000002
Serum fasting glucose measurement, 0.15000000000000002
serum BUN/creatinine ratio, 0.15000000000000002
Cardiopulmonary Exercise Test, 0.15000000000000002
pulmonary vein flows, 0.15000000000000002
fasting lipid panel, 0.15000000000000002
Thyrotropin, 0.15000000000000002
mitral annular velocity, 0.15000000000000002
Increased central venous pressure, 0.15000000000000002
Glycosylated hemoglobin A, 0.15000000000000002
serum biomarkers, 0.15000000000000002
Oral Glucose Tolerance Test, 0.15000000000000002
pulmonary venous inflow pattern, 0.15000000000000002
Left ventricular dilatation, 0.15000000000000002
Magnetic resonance imaging of heart for assessment of myocardial viability, 0.15000000000000002
thyroid-stimulating hormone measurement, 0.15000000000000002
Pulse Pressure, 0.15000000000000002
Norepinephrine measurement, 0.15000000000000002
noninvasive cardiac imaging, 0.15000000000000002
Increased albumin, 0.15000000000000002
Pulmonary Capillary Wedge Pressure, 0.15000000000000002
Mixed venous oxygen saturation measurement, 0.15000000000000002
Arterial oxygen saturation measurement, 0.15000000000000002
UCN3 protein_ human, 0.15000000000000002
Private home-based care, 0.15000000000000002
esmolol, 0.15000000000000002
Venous blood sampling, 0.15000000000000002
Intra-aortic balloon pump device, 0.15000000000000002
UCN2 protein_ human, 0.15000000000000002
Taurine, 0.15000000000000002
valvuloplasty, 0.15000000000000002
Antiplatelet therapy  EXCEPT Aspirin, 0.15000000000000002
multidisciplinary care conference, 0.15000000000000002
Testosterone patch, 0.15000000000000002
Diuresis, 0.15000000000000002
Reperfusion Therapy, 0.15000000000000002
Fontan Procedure, 0.15000000000000002
gene therapy, 0.15000000000000002
Sitting position, 0.15000000000000002
Resistance Training, 0.15000000000000002
Exercise_ Aerobic, 0.15000000000000002
Provider orders for life-sustaining treatment, 0.15000000000000002
Placement of stent, 0.15000000000000002
Nitrates, 0.15000000000000002
percutaneous edge-to-edge repair, 0.15000000000000002
Social support, 0.15000000000000002
neurohumoral antagonists, 0.15000000000000002
Relaxin, 0.15000000000000002
dialysis, 0.15000000000000002
Cardiac rehabilitation, 0.15000000000000002
Aneurysmectomy, 0.15000000000000002
Heart failure education, 0.15000000000000002
Testosterone Transdermal Patch, 0.15000000000000002
Nicotinic Acids, 0.15000000000000002
Home exercise program, 0.15000000000000002
Transmyocardial revascularization by laser technique, 0.15000000000000002
Alcohol Abstinence, 0.15000000000000002
Dexrazoxane, 0.15000000000000002
Inhaled bronchodilator therapy, 0.15000000000000002
Multisite ventricular pacing, 0.15000000000000002
growth hormone treatment, 0.15000000000000002
Nonrebreather oxygen mask, 0.15000000000000002
Dietary sodium - average, 0.15000000000000002
carvedilol-cr, 0.15000000000000002
remote telemonitoring programs, 0.15000000000000002
myoplasty, 0.15000000000000002
Aldactone, 0.15000000000000002
Chelation Therapy, 0.15000000000000002
specialized hf clinics, 0.15000000000000002
cardiac myosin activators, 0.15000000000000002
replacement; valve, 0.15000000000000002
Catheter Ablation_ Electric, 0.15000000000000002
Vasopressin Antagonist, 0.15000000000000002
Anterior, 0.15000000000000002
avp antagonists, 0.15000000000000002
Dual pressure spontaneous ventilation support, 0.15000000000000002
Ring annuloplasty (procedure), 0.15000000000000002
chimeric natriuretic peptide, 0.15000000000000002
CoQ10, 0.15000000000000002
atrial fibrillation surgery, 0.15000000000000002
Dobutamine, 0.15000000000000002
Catheters_ Cardiac_ Laser Percutaneous Myocardial Revascularization, 0.15000000000000002
Mechanical ventilation, 0.15000000000000002
Electrophysiology ablation, 0.15000000000000002
Natural immunosuppression, 0.15000000000000002
patient monitoring: daily weights, 0.15000000000000002
sequential nephron blockade, 0.15000000000000002
Hospitalization, 0.15000000000000002
Echocardiography_ Three-Dimensional_, 0.15000000000000002
Diabetic - good control, 0.15000000000000002
surgical ventricular reconstruction, 0.15000000000000002
Pneumococcal vaccination, 0.15000000000000002
hydralazine-nitrate combination, 0.15000000000000002
coronary revascularisation, 0.15000000000000002
Post-discharge follow-up, 0.15000000000000002
mycophenolate mofetil, 0.15000000000000002
follow-up, 0.15000000000000002
Psychosocial assessment (procedure), 0.15000000000000002
Implantation of CRT-D, 0.15000000000000002
Right ventricular assist device, 0.15000000000000002
bridge to recovery, 0.15000000000000002
Limits sodium intake, 0.15000000000000002
Testosterone, 0.15000000000000002
Intracoronary brachytherapy using fluoroscopic guidance, 0.15000000000000002
Isotonic exercise, 0.15000000000000002
cd-np, 0.15000000000000002
pulmonary vasodilators, 0.15000000000000002
Lytic, 0.15000000000000002
Fluid restriction, 0.15000000000000002
right ventricular pacing, 0.15000000000000002
Percutaneous Coronary Intervention, 0.15000000000000002
Bypass Surgery, 0.15000000000000002
pulmonary arterial vasodilator therapy, 0.15000000000000002
vaptans, 0.15000000000000002
Potassium supplement, 0.15000000000000002
bridge to decision, 0.15000000000000002
bridge to candidacy, 0.15000000000000002
Surgical ventricular restoration procedure, 0.15000000000000002
bridge-to-recovery_ btr, 0.15000000000000002
Disease Management, 0.15000000000000002
Rotational Atherectomy, 0.15000000000000002
Ventriculomyotomy for idiopathic hypertrophic subaortic stenosis, 0.15000000000000002
coordination of care services, 0.15000000000000002
PACEMAKER DDD, 0.15000000000000002
controlling the ventricular rate, 0.15000000000000002
Dopamine, 0.15000000000000002
Magnetic Resonance Angiography, 0.15000000000000002
Sheng-Mai San, 0.15000000000000002
bridge to transplantation, 0.15000000000000002
Ventricular muscle ablation for arrhythmia, 0.15000000000000002
Pulmonary Artery Catheterization, 0.15000000000000002
creatine analogs, 0.15000000000000002
structured telephone support, 0.15000000000000002
Mustard procedure for transposition repair, 0.15000000000000002
Telephone follow-up, 0.15000000000000002
ferric carboxymaltose, 0.15000000000000002
Discharge Planning, 0.15000000000000002
Maze procedure for atrial arrhythmia, 0.15000000000000002
adaptive servo-ventilation, 0.15000000000000002
satavaptan, 0.15000000000000002
discharge education, 0.15000000000000002
Biventricular defibrillator, 0.15000000000000002
Erythropoietin, 0.15000000000000002
Urinary Catheterization, 0.15000000000000002
Atrial inversion operation using atrial wall, 0.15000000000000002
Trimetazidine, 0.15000000000000002
ventricular reconstruction, 0.15000000000000002
Do-Not-Resuscitate Orders, 0.15000000000000002
Implantation of artificial heart, 0.15000000000000002
Cyclosporine, 0.15000000000000002
Artificial Ventricle, 0.15000000000000002
muscle transfer, 0.15000000000000002
wearable defibrillator vest, 0.15000000000000002
Neuromuscular Electrical Stimulation, 0.15000000000000002
Increased protein diet, 0.15000000000000002
Administer oxygen at high flow rate (10-15 L/min), 0.15000000000000002
Maintaining Intravenous Access, 0.15000000000000002
peep, 0.15000000000000002
Intra-Aortic Balloon Pumping, 0.15000000000000002
insulin, 0.15000000000000002
Heart failure follow-up, 0.15000000000000002
Midazolam, 0.15000000000000002
repair of heart valve, 0.15000000000000002
Iron sucrose, 0.15000000000000002
supplemental oxygen therapy, 0.15000000000000002
Magnesium supplement, 0.15000000000000002
destination therapy, 0.15000000000000002
Cardiopulmonary Bypass, 0.15000000000000002
regular physical activity, 0.15000000000000002
disease-modifying neurohumoral antagonists, 0.15000000000000002
percutaneous partial pumps, 0.15000000000000002
Azathioprine, 0.15000000000000002
Glucagon-Like Peptide 1, 0.15000000000000002
Extracorporeal Membrane Oxygenation, 0.15000000000000002
Patient education (procedure), 0.15000000000000002
Cardiac Resynchronization Therapy Pacemaker (CRT-P) Systems, 0.15000000000000002
Care plan, 0.15000000000000002
Cessation of smoking, 0.15000000000000002
nurse-based case management, 0.15000000000000002
continuous intravenous infusion of a positive inotropic agent, 0.15000000000000002
intravenous inotropic support, 0.15000000000000002
Clenbuterol, 0.15000000000000002
Atrial Ablation, 0.15000000000000002
holistic management, 0.15000000000000002
Hawthorn preparation, 0.15000000000000002
Admission to intensive care unit, 0.15000000000000002
Tai Chi, 0.15000000000000002
PACEMAKER VVI PLACEMENT, 0.15000000000000002
telephonic case management, 0.15000000000000002
vasopressin v2 receptor antagonists, 0.15000000000000002
guideline-directed medical therapy, 0.15000000000000002
Etomidate, 0.15000000000000002
Biventricular Pacemakers, 0.15000000000000002
Dor procedure, 0.15000000000000002
passive ventricular constraint, 0.15000000000000002
ghrelin, 0.15000000000000002
Therapeutic immunosuppression, 0.15000000000000002
aldosterone, 0.15000000000000002
Influenza vaccination, 0.15000000000000002
Implantation of permanent intravenous cardiac pacemaker, 0.15000000000000002
Pericardiectomy, 0.15000000000000002
Family counseling, 0.15000000000000002
assisted ventilation, 0.15000000000000002
Lipid-lowering therapy, 0.15000000000000002
Coreg, 0.15000000000000002
maintenance of sinus rhythm, 0.15000000000000002
Metformin, 0.15000000000000002
intracoronary autologous bone-marrow cell transfer, 0.15000000000000002
Repair of tricuspid valve, 0.15000000000000002
Caloric supplementation, 0.15000000000000002
omecamtiv mecarbil, 0.15000000000000002
Bile-acid Binding Resin [EPC], 0.15000000000000002
Implantation of cardiac support device (CSD), 0.15000000000000002
Left ventricular aneurysm, 0.15000000000000002
Deferoxamine, 0.15000000000000002
Referral to cardiac surgery service, 0.15000000000000002
Adrenergic beta-2 Receptor Agonists, 0.15000000000000002
Invasive mechanical ventilation, 0.15000000000000002
Fibrates, 0.15000000000000002
lixivaptan, 0.15000000000000002
infusion of autologous bone marrow-derived cells (bmcs), 0.15000000000000002
Pneumococcal vaccine, 0.15000000000000002
Low sodium diet, 0.15000000000000002
managed in an intensive or coronary care unit, 0.15000000000000002
managed at tertiary heart failure centres, 0.15000000000000002
Demeclocycline, 0.15000000000000002
Somatotropin-Releasing Hormone, 0.15000000000000002
Implantation of rechargeable cardiac contractility modulation [CCM]_ total system, 0.15000000000000002
catheterization with infusion of dobutamine, 0.15000000000000002
Intermittent pneumatic compression device, 0.15000000000000002
left atrial appendage closure, 0.15000000000000002
Thoracic impedance, 0.15000000000000002
Thoracentesis, 0.15000000000000002
Ligation of patent ductus arteriosus, 0.15000000000000002
Exercise education, 0.15000000000000002
improved access to care, 0.15000000000000002
Weight reduction regimen, 0.15000000000000002
Left ventricular assist device, 0.15000000000000002
Directional atherectomy, 0.15000000000000002
High dose, 0.15000000000000002
implantable monitors, 0.15000000000000002
Disease management program (regime/therapy), 0.15000000000000002
Positive inotropic drug, 0.15000000000000002
Cell Therapy, 0.15000000000000002
DIRECT RENIN INHIBITOR, 0.15000000000000002
rosuvastatin, 0.15000000000000002
transitional care planning, 0.15000000000000002
Family education, 0.15000000000000002
aortic valve surgery, 0.15000000000000002
Insertion of dual chamber pacemaker, 0.15000000000000002
Adenosine A1 Receptor Antagonists, 0.15000000000000002
progenitor cell-based myocardial repair, 0.15000000000000002
Controls alcohol intake, 0.15000000000000002
Patient Care Team, 0.15000000000000002
written discharge instructions, 0.15000000000000002
Prosthetic valve, 0.15000000000000002
control hypertension, 0.15000000000000002
Pulmonary artery pressure monitoring, 0.15000000000000002
Prophylactic diuretic therapy, 0.15000000000000002
continuous inotropic infusions, 0.15000000000000002
Transvenous insertion of pacing electrode for left ventricular pacing, 0.15000000000000002
Dietary Supplementation, 0.15000000000000002
palliative care service, 0.15000000000000002
Lorazepam, 0.15000000000000002
Alcohol septal ablation, 0.15000000000000002
Ablation therapy for atrial fibrillation, 0.15000000000000002
Transcatheter mitral valve repair, 0.15000000000000002
Istaroxime, 0.15000000000000002
Peripheral Stem Cell Transplantation, 0.15000000000000002
myomectomy, 0.15000000000000002
Hormone replacement therapy, 0.15000000000000002
aortic valve replacement transcatheter, 0.15000000000000002
Surgical reverse remodeling, 0.15000000000000002
Yoga, 0.15000000000000002
Iron supplement therapy, 0.15000000000000002
lv reconstruction, 0.15000000000000002
modest exercise, 0.15000000000000002
chest pressure, 0.15000000000000002
Bilateral pleural effusion, 0.15000000000000002
Hydralazine / Isosorbide Dinitrate, 0.15000000000000002
Bidil, 0.15000000000000002
fondaparinux, 0.15000000000000002
Left anterior fascicular block, 0.15000000000000002
Catheterization of left heart, 0.15000000000000002
Catheterization of right heart, 0.15000000000000002
Intraventricular pacing, 0.15000000000000002
Swan-Ganz Catheterization, 0.15000000000000002
Replacement of aortic valve (procedure), 0.15000000000000002
Replacement of pulmonary valve, 0.15000000000000002
Replacement of tricuspid valve, 0.15000000000000002
Replacement of mitral valve (procedure), 0.15000000000000002
tolvaptan, 0.15000000000000002
conivaptan, 0.15000000000000002
Self-care interventions, 0.15000000000000002
rofecoxib, 0.15000000000000002
2D Doppler Echocardiography, 0.15000000000000002
Haemofiltration, 0.15000000000000002
Captopril, 0.15000000000000002
Right upper quadrant pain, 0.15000000000000002
Cobalt, 0.15000000000000002
Blood Transfusion, 0.15000000000000002
Bilateral renal artery stenosis, 0.15000000000000002
Dilated cardiomyopathy secondary to familial storage disease, 0.15000000000000002
environmental or medical exposure to cardiotoxic substances, 0.15000000000000002
H/O: alcoholism, 0.15000000000000002
Taxoids, 0.15000000000000002
Family history of conduction disorder of the heart, 0.15000000000000002
Multiple gated acquisition scanning, 0.15000000000000002
Polydipsia, 0.15000000000000002
Ephedra, 0.15000000000000002
Cheyne-Stokes Respiration, 0.15000000000000002
Excessive alcohol consumption, 0.15000000000000002
Tobacco use, 0.15000000000000002
Systemic infection, 0.15000000000000002
Emphysema, 0.15000000000000002
mitral valve papillary muscle rupture, 0.15000000000000002
Hypocalcemia, 0.15000000000000002
Peripheral arterial embolism, 0.15000000000000002
History of myocardial infarction, 0.15000000000000002
ST segment elevation myocardial infarction, 0.15000000000000002
Carnitine deficiency, 0.15000000000000002
Penicillins, 0.15000000000000002
Postcardiotomy syndrome, 0.15000000000000002
isoniazid, 0.15000000000000002
Thromboembolism, 0.15000000000000002
Congenital muscular dystrophy (disorder), 0.15000000000000002
Illicit drug use, 0.15000000000000002
Cerebrovascular accident, 0.15000000000000002
COPD exacerbation, 0.15000000000000002
Transfusion Of Blood Products, 0.15000000000000002
FH: Sudden infant death, 0.15000000000000002
pheochromocytoma, 0.15000000000000002
Atrial Septal Defects, 0.15000000000000002
Supraventricular tachyarrhythmia, 0.15000000000000002
Cardiotoxicity, 0.15000000000000002
Egg intake, 0.15000000000000002
Sulfonamides, 0.15000000000000002
Gaucher Disease, 0.15000000000000002
Dietary sodium - high, 0.15000000000000002
Excessive sodium intake, 0.15000000000000002
Ergot Alkaloids, 0.15000000000000002
regurgitant valvular disease, 0.15000000000000002
Elderly (population group), 0.15000000000000002
concomitant anthracycline therapy, 0.15000000000000002
Right sided infective endocarditis, 0.15000000000000002
Cardiomyopathy_ Familial Idiopathic, 0.15000000000000002
Malnutrition, 0.15000000000000002
H/O: asthma, 0.15000000000000002
worsening hypertension, 0.15000000000000002
Ascending aortic dissection, 0.15000000000000002
Hypertensive crisis, 0.15000000000000002
Restrictive cardiomyopathy secondary to infiltrations, 0.15000000000000002
Fasting hyperglycaemia, 0.15000000000000002
Mitral chordae rupture, 0.15000000000000002
cumulative anthracycline dose, 0.15000000000000002
maternal placental syndrome, 0.15000000000000002
disease (or disorder); valve_ valvular (obstructive) (regurgitation), 0.15000000000000002
Fever, 0.15000000000000002
Doppler echocardiography: extracardiac shunt, 0.15000000000000002
Chloroquine, 0.15000000000000002
Family history of heart failure, 0.15000000000000002
MYOCARDIAL INFARCTION RIGHT VENTRICULAR, 0.15000000000000002
high-fat dairy, 0.15000000000000002
beta Thalassemia, 0.15000000000000002
Paget's Disease of Bone, 0.15000000000000002
Loeffler Syndrome, 0.15000000000000002
Exacerbation of asthma, 0.15000000000000002
Arteriovenous fistula, 0.15000000000000002
Environmental Exposure, 0.15000000000000002
skeletal myopathy, 0.15000000000000002
Sudden unexpected nocturnal death syndrome, 0.15000000000000002
Chronic lung disease, 0.15000000000000002
Hypertensive heart failure, 0.15000000000000002
hemorrhagic stroke, 0.15000000000000002
severe hypertension, 0.15000000000000002
cancer radiation therapy, 0.15000000000000002
Bland White Garland Syndrome, 0.15000000000000002
Pregnancy, 0.15000000000000002
Exposure to toxin, 0.15000000000000002
Liver Dysfunction, 0.15000000000000002
Epirubicin, 0.15000000000000002
Female, 0.15000000000000002
Hyperkalemia, 0.15000000000000002
Dysglycemia, 0.15000000000000002
H/O: thyroid disorder, 0.15000000000000002
Catecholamines, 0.15000000000000002
Somatotropin deficiency, 0.15000000000000002
H/O: diabetes mellitus, 0.15000000000000002
Influenza-like illness, 0.15000000000000002
H/O: angina pectoris, 0.15000000000000002
Estrogens, 0.15000000000000002
Deep Vein Thrombosis, 0.15000000000000002
H/O: heart failure, 0.15000000000000002
Medication Nonadherence, 0.15000000000000002
High density lipoprotein deficiency, 0.15000000000000002
Restrictive cardiomyopathy secondary to familial storage disease, 0.15000000000000002
Environmental Stress, 0.15000000000000002
Lobar Pneumonia, 0.15000000000000002
pickering syndrome, 0.15000000000000002
Chemotherapy Regimen, 0.15000000000000002
HIV Seropositivity, 0.15000000000000002
Fenfluramine, 0.15000000000000002
Placental infarct, 0.15000000000000002
Acute mitral regurgitation, 0.15000000000000002
Diabetic Cardiomyopathy, 0.15000000000000002
Iron deficiency, 0.15000000000000002
Ischemic Cerebrovascular Accident, 0.15000000000000002
Obesity cardiomyopathy, 0.15000000000000002
Dilated cardiomyopathy secondary to toxic reaction, 0.15000000000000002
Itraconazole, 0.15000000000000002
Alcohol consumption, 0.15000000000000002
Abruptio Placentae, 0.15000000000000002
cilostazol, 0.15000000000000002
Aging, 0.15000000000000002
Idiopathic, 0.15000000000000002
Dietary indiscretion, 0.15000000000000002
Uncontrolled hypertension, 0.15000000000000002
Adriamycin, 0.15000000000000002
iatrogenic causes, 0.15000000000000002
Emotional Stress, 0.15000000000000002
FH: Muscular dystrophy, 0.15000000000000002
Tobacco, 0.15000000000000002
Shunt left-right intracardiac, 0.15000000000000002
Licorice, 0.15000000000000002
Permanent atrial fibrillation, 0.15000000000000002
Phentermine, 0.15000000000000002
History of cardiac arrest, 0.15000000000000002
Infectious disease of lung, 0.15000000000000002
Methyldopa, 0.15000000000000002
Actual Non Adherence To Dietary Regime, 0.15000000000000002
hypertensive emergency, 0.15000000000000002
Amphetamine Abuse, 0.15000000000000002
Multiple intracardiac shunts, 0.15000000000000002
Pulmonary arterial hypertension, 0.15000000000000002
Methamphetamine, 0.15000000000000002
Paroxysmal supraventricular tachycardia, 0.15000000000000002
Cancer Diagnosis, 0.15000000000000002
Pseudoephedrine, 0.15000000000000002
Dexfenfluramine, 0.15000000000000002
Tachycardia_ Atrioventricular Nodal Reentry, 0.15000000000000002
MITRAL LEAFLET FLAIL, 0.15000000000000002
anagrelide, 0.15000000000000002
Pergolide, 0.15000000000000002
Exposure to cardiotoxins, 0.15000000000000002
Atrial tachycardia, 0.15000000000000002
Infiltrative disorder, 0.15000000000000002
Beam Radiation of Chest using Electrons, 0.15000000000000002
idarubicin, 0.15000000000000002
Cardiac Tamponade, 0.15000000000000002
acute valvular insufficiency, 0.15000000000000002
Pericarditis_ Constrictive, 0.15000000000000002
Viral myocarditis, 0.15000000000000002
Muscular Dystrophies_ Limb-Girdle, 0.15000000000000002
mediastinum, 0.15000000000000002
Amphotericin B, 0.15000000000000002
Atrial natriuretic peptide increased, 0.15000000000000002
Tobacco smoking behavior, 0.15000000000000002
Streptomycin, 0.15000000000000002
Idiopathic Hypereosinophilic Syndrome, 0.15000000000000002
Methylphenidate, 0.15000000000000002
Fabry Disease, 0.15000000000000002
Ephedrine, 0.15000000000000002
acute, 0.15000000000000002
Tetanus Vaccine, 0.15000000000000002
Cardiac Output_ High, 0.15000000000000002
FH: Cardiomyopathy, 0.15000000000000002
Increased body mass index, 0.15000000000000002
AORTIC REGURGITATION ACUTE, 0.15000000000000002
Cocaine Abuse, 0.15000000000000002
Myopericarditis, 0.15000000000000002
Cardiotoxins, 0.15000000000000002
Patent ductus arteriosus, 0.15000000000000002
Dissection of aorta, 0.15000000000000002
Cocaine Cardiomyopathy, 0.15000000000000002
Retinopathy, 0.15000000000000002
Nonischemic congestive cardiomyopathy, 0.15000000000000002
Anorexia Nervosa, 0.15000000000000002
obstructive valvular disease, 0.15000000000000002
Atrial Flutter, 0.15000000000000002
Congestive heart failure due to valvular disease, 0.15000000000000002
history of mi or acs, 0.15000000000000002
previous history of smoking, 0.15000000000000002
Ventricular pacing at high rates, 0.15000000000000002
Chronic anemia, 0.15000000000000002
bucindolol, 0.15000000000000002
bosentan, 0.15000000000000002
Intra-arterial vasodilator, 0.15000000000000002
tezosentan, 0.15000000000000002
Nesiritide, 0.15000000000000002
Intravenous vasodilator, 0.15000000000000002
sildenafil, 0.15000000000000002
Milrinone, 0.15000000000000002
Carvedilol, 0.15000000000000002
Prazosin, 0.15000000000000002
nebivolol, 0.15000000000000002
Sodium Nitroprusside, 0.15000000000000002
ranolazine, 0.15000000000000002
cinaciguat, 0.15000000000000002
Epoprostenol, 0.15000000000000002
Pre-Eclampsia, 0.15000000000000002
Chronic Kidney Insufficiency, 0.15000000000000002
Influenza, 0.15000000000000002
vesnarinone, 0.15000000000000002
Anabolic steroids, 0.15000000000000002
Abdominal bloating, 0.15000000000000002
Metabolic syndrome, 0.15000000000000002
Noninvasive positive pressure ventilation, 0.15000000000000002
Stable angina, 0.15000000000000002
Exertional angina, 0.15000000000000002
Acute Coronary Syndrome, 0.15000000000000002
Angina_ Unstable, 0.15000000000000002
Alcoholic Intoxication_ Chronic, 0.15000000000000002
Presyncope, 0.15000000000000002
ivabradine, 0.15000000000000002
Flecainide, 0.15000000000000002
Disopyramide, 0.15000000000000002
Class III antiarrhythmic drug, 0.15000000000000002
Phenytoin, 0.15000000000000002
Class I antiarrhythmic drug, 0.15000000000000002
Losartan, 0.15000000000000002
Digitoxin, 0.15000000000000002
dofetilide, 0.15000000000000002
Atenolol, 0.15000000000000002
apixaban, 0.15000000000000002
Warfarin, 0.15000000000000002
rivaroxaban, 0.15000000000000002
dabigatran, 0.15000000000000002
Stenting, 0.15000000000000002
Genetic Counseling, 0.15000000000000002
aliskiren, 0.15000000000000002
Signal-averaged electrocardiography, 0.15000000000000002
12 lead ECG, 0.15000000000000002
Anomalous origin of coronary artery from pulmonary arterial tree, 0.15000000000000002
Premature ventricular contractions, 0.15000000000000002
Palpitations, 0.15000000000000002
Sick Sinus Syndrome, 0.15000000000000002
Sinus bradycardia, 0.15000000000000002
Ventricular Fibrillation, 0.15000000000000002
echocardiography: diastolic chamber volume of left ventricle, 0.15000000000000002
Continuous Positive Airway Pressure, 0.15000000000000002
Right Ventricular Hypertrophy, 0.15000000000000002
Cardiac Hypertrophy, 0.15000000000000002
PET heart study, 0.15000000000000002
Transmyocardial Laser Revascularization (procedure), 0.15000000000000002
Old myocardial infarction, 0.15000000000000002
Spirometry, 0.15000000000000002
Pansystolic murmur, 0.15000000000000002
everolimus, 0.15000000000000002
infliximab, 0.15000000000000002
Etanercept, 0.15000000000000002
Artificial cardiac pacemaker, 0.15000000000000002
Pulmonary artery systolic pressure, 0.15000000000000002
Aortic Valve Stenosis, 0.15000000000000002
Hypertensive cardiomyopathy, 0.15000000000000002
Tachycardia-induced cardiomyopathy, 0.15000000000000002
Takotsubo Cardiomyopathy, 0.15000000000000002
Cardiomyopathy_ Alcoholic, 0.15000000000000002
Arrhythmogenic Right Ventricular Dysplasia, 0.15000000000000002
Ischemic cardiomyopathy, 0.15000000000000002
Left ventricular noncompaction, 0.15000000000000002
Endocardial Fibroelastosis, 0.15000000000000002
Peripartum cardiomyopathy, 0.15000000000000002
Zebeta, 0.15000000000000002
quinapril, 0.15000000000000002
Perindopril, 0.15000000000000002
trandolapril, 0.15000000000000002
Lisinopril, 0.15000000000000002
irbesartan, 0.15000000000000002
candesartan, 0.15000000000000002
Ramipril, 0.15000000000000002
Enalapril, 0.15000000000000002
aldosterone receptor blockers, 0.15000000000000002
omapatrilat, 0.15000000000000002
valsartan, 0.15000000000000002
Fosinopril, 0.15000000000000002
Bronchitis_ Chronic, 0.15000000000000002
Renal arteriovenous malformation, 0.15000000000000002
Gated Blood-Pool Imaging, 0.15000000000000002
Increased diastolic arterial pressure, 0.15000000000000002
Acute posterior myocardial infarction, 0.15000000000000002
Elephantiasis Nostras Verrucosa, 0.15000000000000002
Edema of scrotum, 0.15000000000000002
Tomography_ Emission-Computed_ Single-Photon, 0.15000000000000002
Primary idiopathic restrictive cardiomyopathy, 0.15000000000000002
Transthoracic echocardiography, 0.15000000000000002
2D Echocardiography, 0.15000000000000002
Doppler color flow velocity mapping, 0.15000000000000002
Phonocardiography, 0.15000000000000002
Echocardiography_ Transesophageal_, 0.15000000000000002
Intubation_ Endotracheal, 0.15000000000000002
Familial dilated cardiomyopathy, 0.15000000000000002
Primary idiopathic hypertrophic cardiomyopathy, 0.15000000000000002
atorvastatin, 0.15000000000000002
Paroxysmal nocturnal dyspnea, 0.15000000000000002
Cardiac asthma, 0.15000000000000002
Closure of patent foramen ovale, 0.15000000000000002
Low dose heparin prophylaxis, 0.15000000000000002
Labored breathing, 0.15000000000000002
Respiratory distress, 0.15000000000000002
Dyspnea on exertion, 0.15000000000000002
Orthopnea, 0.15000000000000002
Enhanced external counterpulsation, 0.15000000000000002
Body fluid retention, 0.15000000000000002
Nocturnal cough, 0.15000000000000002
Hemoglobin A1c measurement, 0.15000000000000002
Diastolic hypertension, 0.15000000000000002
Hypertension_ Renovascular, 0.15000000000000002
Malignant Hypertension, 0.15000000000000002
Systolic hypertension, 0.15000000000000002
Myocardial Perfusion Imaging, 0.15000000000000002
Oxidative Stress Analysis, 0.15000000000000002
Systemic Scleroderma, 0.15000000000000002
Percutaneous Transluminal Coronary Angioplasty, 0.15000000000000002
Partial excision of left ventricle of heart, 0.15000000000000002
Dry body weight (observable entity), 0.15000000000000002
Troponin I measurement, 0.15000000000000002
Blood pressure monitoring, 0.15000000000000002
Heart-Lung Transplantation, 0.15000000000000002
Percutaneous transluminal pericardiocentesis, 0.15000000000000002
Somnolence, 0.15000000000000002
CT angiography of coronary arteries, 0.15000000000000002
Nortriptyline, 0.15000000000000002
N terminal pro-brain natriuretic peptide level, 0.15000000000000002
Serum pro-brain natriuretic peptide level, 0.15000000000000002
Bacterial Endocarditis, 0.15000000000000002
Mitral Valve Annuloplasty, 0.15000000000000002
Toprol-XL, 0.15000000000000002
Hypophosphatemia, 0.15000000000000002
Hypokalemia, 0.15000000000000002
Hypernatremia, 0.15000000000000002
Hyponatremia, 0.15000000000000002
Albuminuria, 0.15000000000000002
Right ventricular ejection fraction (observable entity), 0.15000000000000002
Acute myocardial ischemia, 0.15000000000000002
hospice care, 0.15000000000000002
Growth hormone excess, 0.15000000000000002
African American, 0.15000000000000002
Becker Muscular Dystrophy, 0.15000000000000002
Congenitally corrected transposition of the great arteries, 0.15000000000000002
Lithium, 0.15000000000000002
Implantation of right ventricular assist device, 0.15000000000000002
Implantation of left ventricular assist device, 0.15000000000000002
Implantation of biventricular assist device, 0.15000000000000002
Morphine Sulfate, 0.15000000000000002
ECG: left ventricular strain, 0.15000000000000002
ECG: T wave abnormal, 0.15000000000000002
ECG myocardial ischemia, 0.15000000000000002
Electrocardiogram: myocardial infarction (finding), 0.15000000000000002
Wide QRS complex, 0.15000000000000002
Pleural Rub, 0.15000000000000002
precordial thrill, 0.15000000000000002
Raised jugular venous pressure, 0.15000000000000002
Exercise capacity decreased, 0.15000000000000002
Pain or discomfort caused by edema, 0.15000000000000002
Livedo Reticularis, 0.15000000000000002
Flash pulmonary oedema, 0.15000000000000002
Resting Dyspnea, 0.15000000000000002
Tachypnea, 0.15000000000000002
Chest dull to percussion, 0.15000000000000002
Pulse irregular, 0.15000000000000002
Structure of jugular vein, 0.15000000000000002
Nausea, 0.15000000000000002
Increased venous pressure, 0.15000000000000002
Hypovolemia, 0.15000000000000002
Bloated feeling, 0.15000000000000002
Vomiting, 0.15000000000000002
Nocturnal awakening, 0.15000000000000002
Icterus, 0.15000000000000002
Apex beat sustained, 0.15000000000000002
Unable to walk, 0.15000000000000002
diffusely distended veins of neck, 0.15000000000000002
presacral edema, 0.15000000000000002
TRICUSPID REGURGITATION MURMUR, 0.15000000000000002
Jugular venous pressure, 0.15000000000000002
Dizziness, 0.15000000000000002
Early satiety, 0.15000000000000002
diminished mental acuity, 0.15000000000000002
right upper quadrant discomfort, 0.15000000000000002
height of rales, 0.15000000000000002
cool_ mottled extremities, 0.15000000000000002
adequacy of perfusion, 0.15000000000000002
improved exercise duration, 0.15000000000000002
displaced_ diffuse heave, 0.15000000000000002
Hypotension symptomatic, 0.15000000000000002
peripheral coolness, 0.15000000000000002
Hepatomegaly, 0.15000000000000002
tissue wasting, 0.15000000000000002
Hepatojugular reflux, 0.15000000000000002
Diaphoresis, 0.15000000000000002
Pulsus alternans, 0.15000000000000002
Mottled skin, 0.15000000000000002
Irritable Mood, 0.15000000000000002
Hepatic congestion, 0.15000000000000002
Air hunger, 0.15000000000000002
Hypothermia_ natural, 0.15000000000000002
palpable pulmonary artery pulsations, 0.15000000000000002
Impaired exercise tolerance, 0.15000000000000002
Body Height, 0.15000000000000002
signs of peripheral hypoperfusion, 0.15000000000000002
Narrow pulse pressure, 0.15000000000000002
Exercise Tolerance, 0.15000000000000002
cha2ds2-vasc, 0.15000000000000002
Physical activity decreased, 0.15000000000000002
PARASTERNAL LIFT, 0.15000000000000002
blood pressure response to valsalva maneuver, 0.15000000000000002
symptoms related to hypoxemia, 0.15000000000000002
Hypoxia, 0.15000000000000002
Body weight:Cmplx:Enctr^frst:^Patient:Set, 0.15000000000000002
mitral and tricuspid insufficiency murmurs, 0.15000000000000002
Nocturia, 0.15000000000000002
Rhonchi, 0.15000000000000002
loss of mental acuity, 0.15000000000000002
Decreased breath sounds, 0.15000000000000002
palpable filling waves, 0.15000000000000002
Basilar Rales, 0.15000000000000002
Jugular venous pulse, 0.15000000000000002
Diaphoretic, 0.15000000000000002
Disturbance in mood, 0.15000000000000002
Cold extremities, 0.15000000000000002
Peripheral perfusion, 0.15000000000000002
Congestion, 0.15000000000000002
MITRAL REGURGITATION MURMUR, 0.15000000000000002
Muscle Weakness, 0.15000000000000002
pulmonary rales, 0.15000000000000002
Beau's lines, 0.15000000000000002
tricuspid or mitral regurgitant murmur, 0.15000000000000002
Xerostomia, 0.15000000000000002
has-bled score, 0.15000000000000002
improvement in exercise capacity, 0.15000000000000002
systolic hypotension, 0.15000000000000002
Decreased systolic arterial pressure, 0.15000000000000002
overall blood pressure, 0.15000000000000002
Anxiety, 0.15000000000000002
liver edge moderate pulsatile enlargement, 0.15000000000000002
ambulatory, 0.15000000000000002
acute dyspnea, 0.15000000000000002
Jugular vein distension, 0.15000000000000002
Blood pressure systolic and diastolic, 0.15000000000000002
Increased abdominal girth, 0.15000000000000002
Bedridden, 0.15000000000000002
Extremity skin temperature, 0.15000000000000002
Weight Gain, 0.15000000000000002
Ascites, 0.15000000000000002
Right ventricular heave, 0.15000000000000002
Supine hypotension, 0.15000000000000002
Waist Circumference, 0.15000000000000002
Muscular Atrophy, 0.15000000000000002
purple-blue nail bed, 0.15000000000000002
increased time to recover after exercise, 0.15000000000000002
Jugular venous engorgement, 0.15000000000000002
Ileus, 0.15000000000000002
dyskinetic area over the precordium, 0.15000000000000002
examination of apical impulse, 0.15000000000000002
Body Weight decreased, 0.15000000000000002
jugular venous pulsations, 0.15000000000000002
giant v waves, 0.15000000000000002
elevated neck veins, 0.15000000000000002
diminished volume or low-amplitude central arterial (i.e._ femoral or carotid) pulses, 0.15000000000000002
mobility requires assistance, 0.15000000000000002
Anorexia, 0.15000000000000002
Feeling hopeless, 0.15000000000000002
diminished airflow, 0.15000000000000002
Diastolic blood pressure, 0.15000000000000002
cyclic respiration, 0.15000000000000002
positive abdominojugular reflux, 0.15000000000000002
Wheezing, 0.15000000000000002
terry nails, 0.15000000000000002
Pallor, 0.15000000000000002
VENOUS STASIS CHRONIC CHANGE, 0.15000000000000002
Mean Arterial Pressure, 0.15000000000000002
exercise capacity, 0.15000000000000002
Sudden Cardiac Death, 0.15000000000000002
Swollen legs, 0.15000000000000002
Cardiac cachexia, 0.15000000000000002
Bilirubin_ direct measurement, 0.15000000000000002
Magnetic resonance imaging of cardiac ventricles (procedure), 0.15000000000000002
Left ventriculogram, 0.15000000000000002
Magnetic resonance imaging angiography of cardiac ventricles (procedure), 0.15000000000000002
multidetector computed tomography angiography of heart, 0.15000000000000002
Magnetic Resonance Imaging_ Cine, 0.15000000000000002
Obesity_ Abdominal, 0.15000000000000002
Atrio-Biventricular Pacing, 0.15000000000000002
Measurement of liver enzyme, 0.15000000000000002
Alanine aminotransferase measurement, 0.15000000000000002
Inspiratory crackles, 0.15000000000000002
New York Heart Association Classification - Class IV, 0.15000000000000002
New York Heart Association Classification - Class III, 0.15000000000000002
Sinus rhythm, 0.15000000000000002
Herceptin, 0.15000000000000002
Cardiogenic pulmonary edema, 0.15000000000000002
Mitral Valve Stenosis, 0.15000000000000002
Sleep Apnea_ Central, 0.15000000000000002
Obstructive sleep apnoea, 0.15000000000000002
arterial blood gas, 0.15000000000000002
Invasive hemodynamic monitoring (regime/therapy), 0.15000000000000002
Cardiac sarcoidosis, 0.15000000000000002
Clozapine, 0.15000000000000002
Glycogen Storage Disease, 0.15000000000000002
Beriberi, 0.15000000000000002
Sleeplessness, 0.15000000000000002
jaw pain, 0.15000000000000002
arm pain, 0.15000000000000002
Musculoskeletal Pain, 0.15000000000000002
Type 1 diabetes, 0.15000000000000002
Repair of aortic valve without replacement, 0.15000000000000002
Tricuspid Regurgitation, 0.15000000000000002
primary valvular heart disease, 0.15000000000000002
Aortic Regurgitation, 0.15000000000000002
Rupture of papillary muscle, 0.15000000000000002
Myasthenia Gravis, 0.15000000000000002
Pulmonary congestion, 0.15000000000000002
Tacrolimus, 0.15000000000000002
Asthenia, 0.15000000000000002
Atrial sound, 0.15000000000000002
Blood urea nitrogen measurement, 0.15000000000000002
Creatinine measurement_ serum (procedure), 0.15000000000000002
Glomerular Filtration Rate, 0.15000000000000002
Creatinine clearance measurement, 0.15000000000000002
Acute massive pulmonary embolism, 0.15000000000000002
Implantable defibrillator, 0.15000000000000002
Serum uric acid, 0.15000000000000002
Holter monitor 24-hour, 0.15000000000000002
Food_ Supplemented, 0.15000000000000002
Monitoring of cardiac output using continuous esophageal doppler, 0.15000000000000002
Hypercapnia, 0.15000000000000002
rosiglitazone, 0.15000000000000002
Open right ventricular biopsy, 0.15000000000000002
Family history of coronary arteriosclerosis, 0.15000000000000002
Aspirin, 0.15000000000000002
clopidogrel, 0.15000000000000002
person, 0.15000000000000002
